NCT00079794View on ClinicalTrials.gov

Iscar for Supplemental Care in Stage IV Lung Cancer

PHASE2CompletedINTERVENTIONAL
Enrollment

36

Participants

Timeline

Start Date

September 30, 2001

Primary Completion Date

February 29, 2004

Study Completion Date

February 29, 2004

Conditions
Lung Cancer
Interventions
DRUG

Iscar

DRUG

mistletoe

Trial Locations (1)

19107

Thomas Jefferson University, Philadelphia

All Listed Sponsors
lead

National Center for Complementary and Integrative Health (NCCIH)

NIH

NCT00079794 - Iscar for Supplemental Care in Stage IV Lung Cancer | Biotech Hunter | Biotech Hunter